On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease community.

Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer Eligible patients were diagnosed with cancer and ...

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

Eli Lilly, the manufacturer of Mounjaro (tirzepatide), offers a savings card program for eligible participants. Other resources may also be available to help you save on the cost of your Mounjaro ...

There are numerous financial assistance options for those who need help paying for their Biktarvy prescription. These include government programs and a $0 copay program for eligible individuals ...

ST. PAUL, Minn., July 17, 2025 /PRNewswire/ -- Panacea Healthcare Solutions, a leader in revenue cycle and compliance solutions, is proud to announce the launch of RevenueRx: Drug Assistance Program, ...

In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...